MoneyWorks4Me

Bliss GVS Pharma informs about open offer

09 Jun 2026 Evaluate
Bliss GVS Pharma has informed that SBI Capital Markets (Manager to the Open Offer) has submitted a copy of Draft Letter of Offer to the Public Shareholders of Bliss GVS Pharma (Target Company). 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..